Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Plavix
Active Ingredient: Clopidogrel hydrogen sulphate, 97.875mg equivalent to 75mg Clopidogrel
Dosage Form: Film coated tablet
New Zealand Sponsor: Sanofi-Aventis New Zealand Limited
Manufacturers: Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Sanofi Winthrop Industrie, Ambares, France
Sanofi-Synthelabo Limited, Fawdon, Newcastle-upon-Tyne, Tyne & Wear, United Kingdom
Dated this 28th day of August 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).